Oppenheimer & Co’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-37,950
| Closed | -$56.9K | – | 1504 |
|
|
2023
Q1 | $56.9K | Hold |
37,950
| – | – | ﹤0.01% | 1341 |
|
|
2022
Q4 | $37.9K | Sell |
37,950
-1,000
| -3% | -$999 | ﹤0.01% | 1324 |
|
|
2022
Q3 | $70K | Buy |
38,950
+1,300
| +3% | +$2.34K | ﹤0.01% | 1315 |
|
|
2022
Q2 | $109K | Hold |
37,650
| – | – | ﹤0.01% | 1331 |
|
|
2022
Q1 | $104K | Sell |
37,650
-7,700
| -17% | -$21.3K | ﹤0.01% | 1413 |
|
|
2021
Q4 | $211K | Sell |
45,350
-3,350
| -7% | -$15.6K | ﹤0.01% | 1382 |
|
|
2021
Q3 | $414K | Buy |
+48,700
| New | +$414K | 0.01% | 1095 |
|